A buyer’s guide for clinical testing businesses
Clinical Diagnostics Marketing Services
What to buy, what to build and how to measure whether the work helps the right organizations adopt a testing service.
A diagnostic company can buy a new website, a library of scientific content and a well-run advertising campaign, then discover that the interested practice still cannot place its first order.
The missing step might be an account setup nobody owns. It might be uncertainty about specimens, a report format the clinician has not seen or an implementation question that keeps circulating between departments.
Those are useful problems to find before purchasing more reach.
Clinical diagnostics marketing services can include positioning, scientific content, website development, search visibility, professional outreach, sales materials and account onboarding. The value of the package depends on whether those services resolve a specific barrier between a suitable buyer’s interest and appropriate, workable use of the offering.
I would start the buying conversation there. What needs to become clearer? Which decision needs support? What should the customer be able to do when the work is finished?
This guide focuses on commissioning and evaluating marketing work for a defined clinical testing offering. For the wider industry, business models and strategic advisory context, see my diagnostics and clinical research marketing consulting page. For instruments, scientific software and the broader laboratory market, see laboratory marketing.
Here, the task is more specific: buy the right work, give it usable acceptance criteria and connect it to what happens after somebody expresses interest.
Write the decision you need to improve
“We need more awareness” is a starting concern. It is not yet a sufficient brief.
Awareness among whom? A specialist considering a testing service needs different information from a practice manager organizing collection, a health system evaluating a contract or a laboratory assessing an assay for its own operation.
Define one priority audience, one offering and one next decision. Then identify what is stopping that decision from happening today. Interview commercial staff, customer support, operations and the people evaluating the service. Compare their accounts with actual inquiries and stalled opportunities.
A useful brief might say: “Qualified specialty practices understand the clinical context, but too many stop between requesting information and completing account setup. We need to establish which questions remain unresolved, revise the materials and assign the handoff.”
That brief could lead to a different purchase than a broad SEO retainer. It may call first for an onboarding guide, a sample-report walkthrough, clearer routing and a staff-owned response process.
My view is that marketing services become easier to judge when you can name the uncertainty each deliverable is meant to remove. Otherwise, the buyer ends up approving activity because it resembles what a marketing program normally contains.
A deliverable is more useful when you can finish this sentence: “After using it, the buyer should be able to decide…”
For an evidence summary, that might be whether the published evidence applies to the intended context. For an implementation guide, it might be whether the practice can support the collection and ordering process. For an account page, it might be whom to contact and what will happen next.
Commission the work by its purpose
What clinical diagnostics marketing services should produce
The following is a proposed commissioning framework. It is not a requirement to buy every service. Begin with the constraint the business has identified and the people available to review and operate the work.
| Service | Concrete deliverable | Acceptance question |
|---|---|---|
| Buyer and workflow research | Interview findings, decision map and prioritized unresolved questions for one offering. | Can the team distinguish a visibility problem from an evidence, access, implementation or service problem? |
| Positioning and message development | An audience-specific message hierarchy with approved claims, limits and supporting evidence. | Can a suitable buyer explain what the offering is for without inferring benefits the evidence does not establish? |
| Scientific and clinical content | Reviewed evidence summaries, professional education and sample-report explanations. | Can readers locate the relevant population, context, findings and limitations rather than receiving an isolated headline statistic? |
| Website and ordering-path design | A service page, audience routing, inquiry process and clear links to approved ordering resources. | Can the intended user complete the next step without calling to ask how the website works? |
| SEO and search content | An intent map, technical fixes and a small set of genuinely distinct pages. | Does each page answer a different decision or practical question, with a clear place in the existing site? |
| Professional outreach and account campaigns | A qualified account list, audience-specific materials, a follow-up plan and a response owner. | Is the outreach reaching organizations the business can appropriately serve, and does every response have somewhere to go? |
| Sales and onboarding support | Approved conversation guides, implementation materials, an account checklist and handoff rules. | Can another trained colleague carry the account forward without reconstructing the previous conversation? |
| Measurement and improvement | Shared stage definitions, an approved data plan and a recurring review of progress and failure reasons. | Can leadership see where suitable opportunities stall and whether the intervention is helping? |
Ask who maintains each item. A specimen guide, service-area statement or turnaround description is a living operational promise. If the underlying service changes, somebody must know which pages, PDFs, emails and sales materials need to change with it.
A beautiful handoff folder is not a maintenance plan.
Buy a process for handling evidence, not just scientific-sounding copy
A clinical diagnostics business needs writers who can ask precise questions and work productively with scientific, medical, regulatory and operational reviewers.
A claim about analytical performance, a claim about identifying a condition and a claim about improving a patient outcome are different claims. A marketing team should not move from one to another merely because the sentence becomes more persuasive.
The FTC’s health-products guidance addresses diagnostic tests and emphasizes both explicit claims and the overall impression conveyed by advertising. Objective claims need appropriate support before dissemination; what an audience reasonably understands matters alongside the literal wording.1
My practical recommendation is a claim register: the exact approved wording, the relevant offering, the supporting source, necessary limitations, the permitted audience and the reviewer responsible for it. Date it. Record the version. Link the materials that use it.
This is an operating aid for qualified review, not a way for a marketer to determine a test’s regulatory status.
FDA’s IVD labeling resource illustrates why context matters: it addresses intended use, performance characteristics, limitations and specimen information among the applicable labeling requirements.2 Which requirements apply to a particular product or laboratory service needs its own assessment. A generic service-page template cannot settle that question.
Design participates in the claim
A large headline can imply certainty that the nearby evidence does not support. A comparison chart can look authoritative while comparing different populations or endpoints. A stock image and an optimistic caption can suggest an outcome that the text never explicitly promises.
Review the finished page, advertisement or presentation as the reader will encounter it. Keep material limitations near the claim they qualify and legible on a phone. Do not rely on a technical reviewer having approved a different sentence in a different document months earlier.
Good review should make the message clearer. If the approved copy becomes unreadable, bring the writer and reviewer together around the question the reader needs answered. Preserve the scientific boundary while improving the explanation.
The promise should survive being forwarded
Many buying decisions involve someone who never attended the original presentation.
A physician forwards a service page to a practice manager. A commercial lead sends a one-page summary to procurement. An operations colleague opens the attachment without the explanation that accompanied it.
I think this is an underused test of marketing quality: can the document travel without changing meaning?
Give it enough context to stand alone. Identify the offering, intended audience, scope, source date and responsible contact. Put a version on operational resources. When appropriate, link to a maintained source rather than encouraging copies of a document that will become stale.
Then ask someone outside the project to explain what they think the organization is promising. If their interpretation exceeds the intended claim or misses the next step, the material needs more work.
The quality of a handoff is often revealed by the questions people no longer have to repeat.
Illustrative scenarios, not client case studies
Three businesses.
Three different service briefs.
These examples are proposed approaches to hypothetical situations. They do not describe named clients, clinical recommendations or promised results.
01 / A specialty clinical laboratory
Interest arrives.
The first account never activates.
A specialty lab receives relevant professional inquiries, but only a small portion progresses to a working account. Leadership assumes the leads need more persuasive follow-up.
The first useful service is investigation. Review a defined group of inquiries with the commercial and operations teams. Were they clinically and commercially suitable? Who responded? What question did the practice ask? Where did the process stop?
Suppose the hypothetical review finds that prospective practices keep asking the same collection and setup questions. The marketing scope should include an approved onboarding guide, a clear account-request route, a sample-report resource and a named implementation contact.
The service page should separate “I need to understand this offering” from “Our organization is ready to discuss setup.” Both are legitimate next steps, and they require different responses.
Measure: progression of suitable inquiries to agreed setup milestones, time spent at each stage and reasons for non-activation. Review clinical appropriateness with the responsible team rather than treating every additional order as a win.
02 / A diagnostics manufacturer
The demonstration is impressive.
The evaluation has no owner.
A manufacturer promotes an assay and associated platform to clinical laboratories. Conference conversations are strong, but the commercial team cannot explain why evaluations are delayed.
A stronger brief may focus on the evaluation decision: which application is in scope, who needs to participate, what local requirements must be addressed and who is responsible for the next internal step.
The deliverables could include an approved evaluation-discussion guide, a stakeholder-specific presentation and an implementation question list covering training, service, interfaces, consumables and workflow. The organization’s qualified teams retain responsibility for clinical, technical and regulatory decisions.
A campaign can invite the right laboratory leaders into that conversation. It cannot replace the laboratory’s assessment or make an unsupported performance claim true.
Measure: qualified evaluations with an owner, agreed next action and documented decision criteria. A crowded webinar is encouraging; an evaluation that can proceed is a different kind of progress.
03 / A regional testing provider
The campaign reaches beyond the service.
A regional provider attracts inquiries from organizations outside its practical collection or transport coverage. The marketing dashboard looks active, while the service team spends time explaining why the offering is unavailable.
The first work is to reconcile marketing geography with operating geography. Confirm serviceable areas, collection arrangements and the conditions attached to turnaround statements. Reflect those facts in location content, targeting and qualification.
Then examine demand within the area the business can serve. A smaller pool of suitable inquiries may be more valuable than a larger pool built on an unclear promise.
Any expansion in promotion should follow an agreed operational decision. If a new route or collection arrangement is needed, its owner, resources and readiness belong in the launch plan.
Measure: suitable inquiries by serviceable area, onboarding completion, operational exceptions and the contribution of accounts after the costs of serving them.
Build one complete path before multiplying campaigns
I would rather see one offering explained accurately, supported by useful evidence and connected to a working response process than ten offerings promoted through disconnected campaigns.
A pilot gives the team a manageable unit of work. It also exposes dependencies before they become a portfolio-wide problem.
Begin with a shared brief and a baseline
Choose the offering and intended audience. Capture the current journey, the questions that recur and the stages where progress stops. Review what already exists before commissioning replacements. A useful PDF may need a better location and owner rather than a redesign.
Agree on what can realistically change during the engagement. Marketing may clarify information and route inquiries, while an interface project or a contracting issue needs a different team and timetable.
Produce and review the connected materials
Build the page, evidence summary, response templates and onboarding resources as parts of the same experience. Use consistent terminology. Route professional, patient, billing and existing-customer requests appropriately rather than sending every form to a general sales queue.
Test a hypothetical inquiry from arrival through handoff. Verify who receives it, what they see, what they send back and how another colleague can continue the conversation.
Launch within actual capacity
Someone needs time to answer the inquiries, conduct evaluations and help organizations get started. Calculate that workload before increasing promotion.
For illustration, if ten new accounts each need three hours of onboarding support, that is 30 hours of onboarding work. A team with 18 hours available has a 12-hour gap before allowing for rework or unexpected requests. Advertising efficiency does not remove that gap.
Adjust launch volume, staffing, the process or the promise. Then review whether the actual workload resembles the estimate. More interest is only useful when the business can respond competently.
A brief worth sending to a prospective partner
What the first phase should contain
- Offering and audience
- One defined clinical testing service or product, its relevant market and the professional audience whose decision the work should support.
- Observed constraint
- The evidence for the problem: recurring questions, stalled-account patterns, unclear web journeys or mismatched inquiries. Label assumptions that still need investigation.
- Outputs
- A decision map, approved message and claim register, one priority page, the supporting resources and a tested response workflow.
- Review owners
- Named scientific, medical, regulatory, privacy, operational and commercial reviewers as applicable, with time reserved for their decisions.
- Acceptance
- Agreed facts represented accurately; working forms and routing; usable mobile layout; accessible navigation; documented handoffs; approved measurement.
- Learning period
- A review window appropriate to the buying cycle, with baseline definitions, interim indicators and reasons for delay recorded.
- Handover
- Editable materials, access under the client’s control, source records, maintenance ownership and clear instructions for future updates.
Count progress that the operation recognizes
Clicks, downloads and inquiries can help describe activity. They do not establish adoption on their own.
Define stages with the people who operate the service. A possible sequence is an appropriate inquiry, a qualified organization, a completed setup milestone and a first appropriate use. Ongoing use needs interpretation in the context of the offering and the customer’s real needs.
There is no universal correct ordering frequency. A specialist service can be valuable without generating routine weekly volume.
Keep the denominator visible
Suppose 40 organizations inquire, 20 meet the agreed qualification criteria and eight complete setup. That is 20% of all inquiries and 40% of qualified inquiries. Both calculations are correct, but they answer different questions.
Compare cohorts that have had enough time to progress. If this month’s inquiries are still waiting for contracting or review, comparing them with a fully matured cohort can create a misleading decline.
Record disqualification and delay reasons. An organization outside the service area, an unresolved evidence question and a missing form field should not all disappear into “lost lead.”
Keep attribution proportionate to the evidence
A clinical account may have encountered publications, professional peers, conferences, sales conversations and the website before it contacts the business. An analytics platform’s last recorded interaction is not the full history of that decision.
Use approved aggregate data, account-level progress and structured feedback to understand contribution. Where feasible, compare a defined pilot with a relevant baseline or staged rollout. Do not turn a correlation into a claim that a campaign caused clinical improvement.
Build measurement around appropriate data access
Separate business-development information from patient and clinical records. A marketing form should not invite diagnostic reports simply because a free-text field is convenient. Give patient-related requests a suitable route.
HHS guidance addresses tracking technologies used by HIPAA-regulated entities and includes a notice that part of its position on unauthenticated public webpages was vacated by a court.3 Review the actual data flows, applicable obligations and vendors with qualified privacy and security owners. Neither installing a familiar analytics product nor adding a consent banner settles that review.
The measurement plan should be explicit about which information is collected, where it goes, who can access it and what the report can honestly establish.
Evaluate the proposed work before evaluating the sales presentation
A good prospective partner should be able to explain its first questions, its review process and how its deliverables will be used. It should also be able to identify decisions it cannot make on the client’s behalf.
Ask for a sample scope with acceptance criteria. Ask how a scientific reviewer’s correction travels into web copy, sales slides and campaign material. Ask how the team handles a claim that has lost its supporting evidence or a service promise operations can no longer meet.
Compare proposals by what they include: research depth, writing and design, number of offerings, development, review rounds, implementation, media management and ongoing maintenance. Separate advertising spend and external costs from professional fees.
A low price can omit the work that makes the engagement usable. A high price can also buy impressive presentation without resolving the problem. The comparison needs a shared brief.
Should we begin with SEO or paid campaigns?
Begin with the constraint. If suitable buyers cannot find the offering and the information and response path are ready, acquisition work may be appropriate. If relevant inquiries already stall after contact, investigate the handoff before paying for more of the same traffic.
How soon should we expect results?
Agree separately on delivery milestones and commercial outcomes. Publishing reviewed materials and fixing a broken inquiry path can be verified promptly. Account activation and adoption depend on the buying cycle, review requirements and operational readiness. Set the evaluation window from those facts rather than a generic promise.
Do we need a new page for every keyword?
No. A distinct audience question or decision may justify a page. A synonym usually does not. This article is a service-buying guide; the linked diagnostics consulting page provides the wider strategic and industry context. That separation should remain visible in titles, content and internal links.
What should remain under our control?
Your organization should have appropriate control of its domain, website, analytics configuration, advertising accounts and approved source materials. Agree on access, editable deliverables, licenses, handover and maintenance responsibilities in the scope.
A useful engagement leaves the next decision easier.
The physician should be able to find the relevant explanation. The practice manager should know how implementation begins. The commercial team should know who is ready for a conversation. The reviewer should be able to trace a claim to its source. Leadership should understand what has improved and what still needs work.
That is the standard I would use when buying clinical diagnostics marketing services.
I can help define the brief, connect the evidence and customer experience, and lead the marketing work around the organization’s qualified scientific and operational teams. My diagnostics and clinical research consulting overview explains the wider scope. If the immediate challenge is deciding what to commission, bring the offering, the audience and the point where progress stops.
Those three things are a better beginning than a list of channels.